Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-01-10Clinical Trial Update: Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial update evaluating erlotinib for recurrent or progressive glioblastoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Efficacy of Protracted Temozolomide in Patients With Progressive High Grade Glioma [Phase 2]
This Phase 2 clinical trial evaluates the efficacy of protracted temozolomide in patients with progressive high-grade glioma, including glio…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Ketogenic Diet for Recurrent Glioblastoma [Phase 1]
A Phase 1 trial evaluating the ketogenic diet for recurrent glioblastoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas [Phase 2]
A Phase 2 trial evaluating bevacizumab plus irinotecan in recurrent gliomas (glioblastoma and astrocytoma) has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma [Phase 2]
A Phase IIb trial of AP-12009, a TGF-β2 antisense oligonucleotide, for recurrent or refractory high-grade glioma including glioblastoma and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-11-06Clinical Trial Update: Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas [Phase 3]
This is a Phase 3 trial evaluating whether adding photodynamic therapy to standard surgery, radiation therapy, and chemotherapy improves tre…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial update showing completion of Phase 1 and Phase 2 studies of NPC-08 for newly diagnosed malignant glioma and recurrent gliobla…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas [Phase 1]
This is a completed Phase I trial evaluating an oral combination of topotecan and temozolomide for malignant gliomas, including glioblastoma…
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs [Phase 1]
Phase 1 trial update of PTK787/ZK 222584 in combination with temozolomide and radiation for glioblastoma patients taking enzyme-inducing ant…
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme [Phase 1]
A Phase 1 trial of boron phenylalanine with or without mannitol for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Phosphorus 32 in Treating Patients With Glioblastoma Multiforme [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating phosphorus-32 for treating glioblastoma and currently lists an unknown statu…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
This is a Phase 2 trial update reporting on cediranib (AZD2171) in adults with recurrent glioblastoma multiforme and related brain tumors; t…
-
FDA approval · 2013-08-16FDA Approved: GLIADEL — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLIADEL (carmustine) by Azurity Pharmaceuticals, Inc. The approval updates the product’s labelin…
-
FDA approval · 2013-08-15FDA Approved: GLEOSTINE — Supplemental Application (NextSource Biotechnology, LLC)
The FDA approved a supplemental application for Gleostine (lomustine) submitted by NextSource Biotechnology, LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 3]
This Phase 3 trial evaluating radiation therapy plus chemotherapy for supratentorial glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) in combination with temozolomide and irinotecan for unresectable, multifocal glioblastoma mul…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and temozolomide with radiation therapy in adults with glioblastoma and rel…
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Ph II Bevacizumab + Etoposide for Pts w Recurrent MG [Phase 2]
Phase II study evaluating bevacizumab plus etoposide in patients with recurrent malignant glioma (glioblastoma and gliosarcoma) completed; r…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma [Phase 1]
A Phase I study evaluating vorinostat in combination with bevacizumab and irinotecan for recurrent glioblastoma. The trial status is complet…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating NBI-3001 followed by surgery in patients with recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating gefitinib for newly diagnosed glioblastoma multiforme has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/2 trial investigating temozolomide plus carboplatin for recurrent glioblastoma multiforme has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of vorinostat and bortezomib in adults with progressive or recurrent glioblastoma multiforme; the…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas [Phase 1]
A Phase 1 trial evaluating motexafin gadolinium with MRI-guided surgery for high-grade gliomas has completed.